The use of immunohistochemical stains (i.e. CD10 for renal cell carcinoma or thyroid transcription factor-1 for thyroid carcinoma) may provide clarity in poorly differentiated tumors or in tissue with dense inflammation. This evidence concerns the gene NKX2-1 and hereditary clear cell renal cell carcinoma.